迦南科技(300412.SZ)一季度扣非淨利潤預增100.83%-141.81% 在手訂單12億元
格隆匯3月31日丨迦南科技(300412.SZ)披露2022年第一季度業績預吿,預計2022年第一季度實現歸屬於上市公司股東的淨利潤1613.57萬元-1936.28萬元,同比增長50%-80%;扣除非經常性損益後的淨利潤1581.57萬元-1904.28萬元,同比增長100.83%-141.81%。
報吿期內,公司嚴格按照制定的發展規劃和經營目標,持續完善管理運營平台,積極推進內生式增長與外延式發展,逐步落實“固體制劑智能工廠整體解決方案供應商”和大健康產業戰略佈局;下游製藥行業需求較為強勁,致使項目訂單穩步增長;截至2022年3月31日,在手訂單約12億元(不含税),其中製藥裝備訂單超10億元(不含税)。
報吿期內,公司持續穩步提升各項業務運營效能,優化收入結構,全產業鏈上下游業務協同發展,確保公司口服固體制劑製藥裝備、生物製劑製藥裝備及各業務板塊繼續保持穩步發展;同時,公司繼續加大對新市場的開拓力度與新產品的研發投入,強化品牌效應與營銷網絡渠道建設,提高產品質量,主要業務單元穩步開展,確保了經營業績平穩增長,致使公司淨利潤有所增長。
報吿期內,預計影響公司淨利潤的非經常性損益金額約為32萬元,主要系政府補助收入和理財產品收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.